Benjamin Bielak serves as Executive at iSpecimen Inc., where they oversee executive responsibilities. Since joining the company, Benjamin Bielak has executed 8 insider transactions totaling $13.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 14, 2023 involved purchasing 18,000 shares valued at $13.0K.
Benjamin Bielak currently holds 84,348 shares of iSpecimen Inc. (ISPC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin Bielak has been a net buyer of ISPC stock. They have purchased $13.0K and sold $0 worth of shares.
Benjamin Bielak's most recent insider trade was on Sep 14, 2023, when they purchased 18,000 shares at $0.72 per share.
Get notified when new Form 4 filings are submitted
| $2.36 |
| Discretionary |
| Nov 30, 2021 | ISPC | $282 | Discretionary | 282 | $1.00 | Discretionary |
| Nov 29, 2021 | ISPC | $1.5K | Discretionary | 1,465 | $1.00 | Discretionary |
| Sep 1, 2021 | ISPC | $282 | Discretionary | 282 | $1.00 | Discretionary |
| Jul 30, 2021 | ISPC | $0 | Award | 47,349 | $N/A | Discretionary |
| Jul 2, 2021 | ISPC | $1.5K | Discretionary | 1,466 | $1.00 | Discretionary |
| Jun 16, 2021 | ISPC | $18.7K | Discretionary | 18,652 | $1.00 | Discretionary |